• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Tony Cen
Tony Cen

Tony Cen

Associate

  • Shanghai China
Contact Me Today
+86 21 6247 7247
vCard
Email me Call me

Tony is an associate at the Taylor Wessing Shanghai Office. He has several years of practice experience and is focusing on corporate M&A and general corporate matters. He advises multinational companies from various sectors on their daily business operations, particularly on the regulatory side.

Tony studied law at East China University of Political Science and Law, where he obtained his LLB degree in 2020, and in the same year, he was admitted to the Chinese bar. He then completed his LLM degree in 2021 at London School of Economics and Political Science. Before joining Taylor Wessing, he worked at a leading Chinese law firm’s Shanghai office from 2022 to 2025, specializing in cross-border corporate matters.

Expertise

Services and Groups

Corporate/M&A & capital markets

Sectors

Life sciences & healthcare

CV

Since 2025 Associate, Taylor Wessing, Shanghai
2022 - 2025 Associate, Zhonglun Law Firm, Shanghai
2020 Bachelor's Degree, East China University of Political Science and Law, China
2021 Master of Law Degree, London School of Economics and Political Science

Career

Since 2025 Associate, Taylor Wessing, Shanghai
2022 - 2025 Associate, Zhonglun Law Firm, Shanghai

Education

2020 Bachelor's Degree, East China University of Political Science and Law, China
2021 Master of Law Degree, London School of Economics and Political Science

Additional languages

English

Related news & insights

FinTech Stories
Fintech

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

22 April 2026

by Miroslav Đurić, LL.M.

Click here to find out more
ivdr mdr
Medical devices

Proposed Amendments to the EU Medical Device Regulation

15 April 2026
Briefing

by Bartosz Świdrak

Click here to find out more
biotech helix
Biotech

Impact of the new Biotech Act on Clinical Trials in the EU

15 April 2026
Quick read

by Irina Rebin

Click here to find out more
Life sciences & healthcare

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

15 April 2026
Briefing

by Irina Rebin

Click here to find out more
Road Marking
Corporate/M&A & capital markets

Advising Eurofins on the sale of its electrical and electronic testing business for EUR575 million

14 April 2026

by Paul Thorpe and Jack Coventry

Click here to find out more
Inside the Office Building
Corporate/M&A & capital markets

Advising on Sona's US$45 million Series B funding

8 April 2026

by multiple authors

Click here to find out more
Flag of the European community
Life sciences & healthcare

Life Sciences Legal Lens – Vol. 1

7 April 2026
Click here to find out more

Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel

1 April 2026

by multiple authors

Click here to find out more
International life sciences
Artificial intelligence

Hungary opens health data infrastructure for AI development

1 April 2026
Briefing

by János Kopasz, AIGP, CIPP/E, CIPM

Click here to find out more
International life sciences
Medical devices

No claim for damages as a result of participation in clinical drug trials

1 April 2026

by Irina Rebin

Click here to find out more
View all insights

Related people

China
Global

Christoph Hezel

Partner

Shanghai
+86 21 6247 7247
Email me
View profile

Michael-Florian Ranft

Partner

Munich
+49 89 21038 0
Email me
View profile

Stella Yang

Counsel

Shanghai
+86 21 6247 7247
Email me
View profile
Full team

Dr. Daniel Werner (geb. Jarzembowski)

Salary Partner

Hamburg
+49 40 36803 0
Email me
View profile

Ercan Cömert

Senior Associate

Frankfurt
+49 69 97130 0
Email me
View profile
Corvin Gutzeit

Corvin Gutzeit

Associate

Hamburg
+49 40 36803 0
Email me
View profile

Amala Atieh

Senior Counsel

Dubai
+971 43 09 10 00
Email me
View profile
Richard Faichney

Richard Faichney

Partner

London
+44 207 300 4773
Email me
View profile
Nell Cooper

Nell Cooper

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Michael Stein

Michael Stein

Partner

Frankfurt
San Francisco
+49 69 97130 0
Email me
View profile
Jan Riebeling

Dr. Jan Riebeling

Partner

Hamburg
+49 40 36803 0
Email me
View profile
Ian Moore

Ian Moore

Partner

London
+44 20 7300 4664
Email me
View profile
Emile Vanrobaeys

Emile Vanrobaeys

Associate

Brussels
+32 2 320 22 53
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing